Schedule 13G ownership disclosure

Ironwood Pharmaceuticals Inc

Class A Stock · CUSIP: 46333X108

Event date: 2025-02-28

Filing-level shares
11,284,399.00
Percent of class
7.1%
  • BlackRock, Inc.

    Shares: 11,284,399.00 · Class: 7.1%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001060021-25-000038
Form type
SCHEDULE 13G/A
Filer
BlackRock, Inc.
CIK
CIK 2012383
Filed
Mar 07, 2025
Reporting period
Feb 28, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub